<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies of 68 patients who developed secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> (SL)/<z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoietic syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e>) after extensive chemotherapy and/or radiation therapy as well as patients who developed SL/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e> without such treatment showed that those patients who received radiation alone or with chemotherapy had more extensive numerical and structural abnormalities than those who received only chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>In terms of the specific chromosomal abnormalities, there are no differences between the various treatment groups </plain></SENT>
<SENT sid="2" pm="."><plain>Hypodiploidy is the most common form of <z:mp ids='MP_0004024'>aneuploidy</z:mp> in these patients, with the most common numerical abnormality being the loss of chromosome 7 </plain></SENT>
<SENT sid="3" pm="."><plain>The most common structural abnormalities involved chromosomes 3 and 5 </plain></SENT>
<SENT sid="4" pm="."><plain>When compared with patients with de novo <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DMS</z:e>, the chromosomal abnormalities in these patients are more complex and extensive </plain></SENT>
<SENT sid="5" pm="."><plain>Serial studies revealed that cytogenetic abnormalities do not precede the development of hematologic changes by significant time periods </plain></SENT>
</text></document>